Voglibose are alpha-glucosaide inhibitor used to reduce the levels of post-prandialblood sugar in people with diabetes mellitus. Voglibose delay the absorption of glucose, thereby reducing risk of macrovascular complications.
Indications:
To treat diabetes mellitus.
Dosage:
By mouth (orally) 0.2 mg before meals.
May increase the dose to 0.3 mg by mouth (orally), 3 times daily before meals.
Implementation:
Give the dose to begin eating first.
Side Effects:
Gi effects such as flatulence, swelling. Hepatotoxicity may occur with Acarbose.
It may give impetus to the emergence of adverse GI reactions.
Special Instructions:
Should be avoided in patients with GI disorders
No comments:
Post a Comment